/Investor DB

OS Fund — Full Portfolio

42 tracked investments · listed companies and verified rows first

Ginkgo Bioworksginkgo.bioin𝕏NYSE: DNAJan 2015

Ginkgo Bioworks builds autonomous labs that accelerate bioengineering for applications in pharmaceutical, agricultural, and industrial biotechnology.

AgTechAI & Machine LearningBiotechDeep TechHealthtechRoboticsBoston, US

Jason Kelly(Co-founder and CEO)inReshma Shetty(Co-founder; President, Chief Operations Officer)inBarry Canton(Co-founder)inAustin Che(Co-founder)inTom Knight(Founder; Ginkgo Fellow)inPeter Boynton(Director)

Co-investors11.2 CapitalAllen Institute for AI (AI2) IncubatorAzure Capital PartnersB3 HoldingBlue Owl CapitalCannage Capital+58 more

Vergelabsvergelabs.comin✓ verified

Verge Labs develops vBx-1.0, a multi-modal biological foundation model trained on proprietary patient data that reasons about neurological disease at the patient level by integrating brain biology, blood biomarkers, and clinical trajectories.

AI & Machine LearningBiotechData & InfrastructureDeep TechDigital Health

Alice Zhang(CEO)Emily Ripka(Head of Product & Engineering)in

Co-investorsThreshold Ventures

3Scan3scan.comNov 2014

San Francisco, US

Todd Huffman(Executive Officer, Director)Megan Klimen(Executive Officer)

BoardJoshua Wolfe(Director)Matt Ocko(Director)inAdam Goulburn(Director)inAdam Goulborn(Director)

Co-investorsComet LabsDolby Family VenturesRecode VenturesDCVC (Data Collective)Dimension CapitalLux Capital

3T Biosciences3tbiosciences.comin𝕏

3T Biosciences develops TCR-based immunotherapies for cancer using a proprietary platform that combines machine-learning algorithms with immunological research to identify and validate T cell receptor targets.

AI & Machine LearningBiotechHealthtechMedical DevicesSouth San Francisco, US

K. Christopher GarciaMarvin Gee(Founder)in

Co-investorsAsset Management CompanyCollaborative FundCRV (Charles River Ventures)Westlake Village BioPartnersMenlo VenturesStarlight Ventures+1 more

A-Alpha Bioaalphabio.comin𝕏

A-Alpha Bio uses synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions for pharmaceutical discovery and development.

AI & Machine LearningBiotechDeep TechSeattle, US

David Younger, PhD(Chief Executive Officer & Co-Founder)Randolph Lopez, PhD(Chief Technology Officer & Co-Founder)David Younger(Executive Officer, Director, Promoter)inRandolph Lopez(Founder)in

Co-investorsAngel Collective Opportunity FundBreakout VenturesFarvatn VentureLux CapitalMadrona Venture GroupBoom Capital Ventures

Apollo Researchapolloresearch.aiin𝕏Seed · Jan 2025

Apollo Research develops AI safety technology focused on understanding and mitigating risks from advanced AI systems that may pursue misaligned objectives.

AI & Machine LearningDefense TechGovTech

Co-investorsJuniper Ventures Management, LlcSeldon Labs

Arzedaarzeda.comin𝕏Series A · Jul 2017 · $15M

Arzeda designs proteins and metabolic pathways using computational tools, including its Archytas protein design software and Scylax metabolic pathway design software.

AI & Machine LearningBiotechDeep TechFoodTechNew MaterialsSeattle, US

Alexandre Zanghellini(Co-Founder & Chief Executive Officer)inEric Althoff(Executive Officer, Director, Promoter)inDavid Baker(Co-founder and Scientific Advisor)Bill Baum(Director)inAndrew Ban(Executive Officer)Daniela Grabs(Executive Officer)

Co-investorsCirculate CapitalFall Line CapitalSofinnova PartnersSustainable Conversion VenturesContinental Grain CompanyLewis & Clark AgriFood+2 more

Atomwiseatomwise.comin

Atomwise uses artificial intelligence and machine learning to discover novel small-molecule drugs, with a current focus on developing treatments for immune and inflammatory diseases.

AI & Machine LearningBiotechDeep TechSan Francisco, US

Izhar Wallach(Executive Officer, Director)inAbraham Heifets(Executive Officer, Director, Promoter)Yan Zhao(Executive Officer)inStephen Worland(Executive Officer, Director)

BoardRobert Mittendorff(Director)inAdam Seabrook(Director)in

Co-investorsAurum Venture PartnersB Capital GroupCerity Partners VenturesCreative Destruction Lab (CDL)Draper AssociatesMission and Market+7 more

Augbioaugbio.com

Augbio (trading as Vaxanix) develops immuno-oncology therapeutics including multi-neoantigen cancer vaccines and CAR-T cell therapies designed to address antigen escape in solid and hematological tumors.

AI & Machine LearningBiotechDeep TechHealthtechMedical Devices

Catalogcatalogdna.comin𝕏

Biomemory develops DNA-based data storage systems for data centers, offering an alternative storage tier optimized for long-term archival, density, and energy efficiency.

Climate TechData & InfrastructureDeep Tech

Hyunjun Park(CEO)

Co-investorsCivilization Ventures Management, LlcFifty YearsHemisphere Ventures LLCNew Enterprise Associates (NEA)Prefix CapitalZ Venture Capital+3 more

Catalogcatalog.worksin𝕏

Catalog is a platform where musicians sell their music directly to fans, with artists getting paid at the moment of purchase.

Creator EconomyMarketplacesMedia & Entertainment

Hamish Gunasekara(Founder)in

Co-investors1confirmationInflection.xyzKindred VenturesDCVC (Data Collective)New Enterprise Associates (NEA)SOSV+1 more

Elysium Healthelysiumhealth.comin

Elysium develops healthcare products focused on aging research and healthy aging rather than disease treatment.

HealthtechLongevityWellness & FitnessNew York City, US

Leonard Guarente, Ph.D.(Co-founder & Chief Scientist)Dan Alminana(Founder)in

Co-investorsBreyer CapitalSprint VcThe Venture Collective

Emerald Cloud Labemeraldcloudlab.comin

Emerald Cloud Lab (ECL) provides remote, cloud-based access to a life science research laboratory, letting researchers run and automate experiments and workflows without a physical lab.

BiotechCloud ComputingDeep TechAustin, US

Brian Frezza(Founder)inD.J. Kleinbaum(Founder)in

Co-investorsAlumni VenturesBlue Ivy VenturesGigafundMerck Global Health Innovation FundMSD Global Health Innovation FundSchooner Capital+2 more

Emulate Bioemulatebio.comin𝕏

Emulate builds Organ-on-a-Chip systems, including platforms, consumables, and pre-assembled BioKits with validated human cell models, to support drug discovery research.

BiotechDeep TechHealthtech

Donald Ingber(Scientific Founder, Board Member, Scientific Advisory Board Chairman)inDaniel Levner(Co-Founder & CTO)inJim Corbett(CEO, Board Member)inLorna Ewart(Chief Scientific Officer)in

Co-investors+ND CapitalNorthpond VenturesAlumni VenturesAlwyn CapitalFourth RealmStray Dog Capital+2 more

Extropicextropic.aiSeed · Dec 2023 · $14M

Extropic builds thermodynamic computing hardware, including thermodynamic sampling units (TSUs) designed to be more energy efficient than GPUs for probabilistic AI workloads.

AI & Machine LearningDeep TechHardwareSemiconductorsAustin, US

Guillaume Verdon(Founder)in

Co-investorsAtacama VenturesBeyond CapitalBlack FlagHOF CapitalHyperguapInfinite Capital+10 more

Ginkgoginkgo-hq.dein

ginkgo offers a digital, ETF-based and commission-free occupational pension (betriebliche Altersvorsorge/bAV) product, along with an employee app and an HR/People platform that integrates with HRIS and payroll systems.

FintechHR TechSaaS

Co-investorsCaesar VenturesHeartfelt CapitalDCVC (Data Collective)Felicis VenturesiGlobe PartnersT. Rowe Price

Ginkoheyginko.comin

Ginko offers a tap-in, tap-out device and system that helps children build healthy screen-time habits by making each use of technology an intentional choice, and connects kids' online interests to real-world activities.

ConsumerHardwareWellness & Fitness

Co-investorsAzure Capital PartnersSwizzle VenturesWildwood VenturesDCVC (Data Collective)Felicis VenturesiGlobe Partners+1 more

Grobiogrobio.comin𝕏

GRObio (GRO Biosciences) develops protein therapeutics using non-standard amino acids (NSAAs) via its GRO platform, aiming to improve protein potency, stability, and function.

BiotechDeep TechHealthtechCambridge, US

Daniel J Mandell(Chief Executive Officer)Tracey Lodie(Executive Officer)inChristopher Gregg(Director)

BoardMing Fang(Director)Bruce Beutel(Director)Dan Becker(Director)

Co-investorsLeaps by BayerREDMILEAlumni VenturesDigitalis VenturesDreamers VCRising Tide+3 more

Helix Nanotechnologieshelixnano.comin𝕏

Helix Nanotechnologies develops mRNA-based therapeutics for disease treatment and environmental applications, currently advancing a COVID-19 vaccine candidate for immunocompromised patients and testing interventions targeting climate challenges.

AI & Machine LearningBiotechHealthtechBoston, US

Nikolai Eroshenko(Founder/CSO)inHannu Rajaniemi(Founder)in

Co-investorsAlumni VenturesBascom VenturesBeast VenturesChampion Hill VenturesDCVC (Data Collective)Fifty Years+14 more

Justju.stin𝕏

A plant-based egg company that creates egg products from plant ingredients as an alternative to conventional egg production.

ConsumerFoodTechEmeryville, US

Josh Tetrick(Founder)in

Co-investorsBlue Horizon CorporationCollaborative FundDynabrand VenturesNew Ground VenturesRadicle ImpactSnatched Ventures+3 more

Kenota (formerly ExVivo Labs)kenota.comin𝕏Defunct

The site is a Vietnamese-language affiliate/review portal that ranks and rates online lottery ("lô đề") betting operators, offering comparisons of payout ratios, licensing, payment methods, and security.

ConsumerHealthtechMedia & EntertainmentMedical DevicesKitchener, CA

Moufeed Kaddoura(Founder/CEO)inEric Blondeel(Founder/| CTO)in

Co-investorsBeaconsfield CapitalFifty YearsJude GomilaMetaplanetNorthtech Capital InvestorsUpslope Ventures+10 more

Lucira Healthlucirahealth.comin

Lucira Health manufactures portable diagnostic devices that connect to smartphones to test bodily fluids for infectious diseases, enabling rapid results outside of clinical settings.

BiotechHealthtechMedical DevicesEmeryville, US

Debkishore Mitra(Founder)inJohn R. Waldeisen(Director)

BoardErik T. Engelson(Executive Officer, Director)Justin Butler(Director)Tuff Yen(Director)Steve Tablak(Director)

Co-investors11.2 CapitalForesite CapitalShangBay Capital LLCY CombinatorDCVC (Data Collective)DHVC+5 more

Lygoslygos.comin𝕏Series A · Dec 2016 · $13M

Lygos uses genetically engineered microorganisms to produce industrial chemicals from sugar feedstocks, focusing on compounds where fermentation offers cost advantages compared to fossil fuel-based manufacturing.

Climate TechHealthtechSan Francisco, US

Eric Steen(Founder/CSO)inJeffrey A. Dietrich(Executive Officer, Director)inJay D. Keasling(Director)

BoardLeonard Katz(Director)

Co-investorsFifty YearsFundersClubJude GomilaLG Technology VenturesY Combinator10x Founders+10 more

Matternetmatternet.comin𝕏

Matternet develops drone-based logistics systems for autonomous transport and delivery.

HardwareLogistics & Supply ChainRoboticsMountain View, US

Andreas Raptopoulos(Founder & CEO)inAlexander Norman-Elvenich(Executive Officer)Jason Secore(CFO)inAlex Norman(COO)in

BoardSaurabh Ranjan(Director)Chris Dawson(Director)in

Co-investorsBoeing HorizonX VenturesComet LabsDRONE FUNDFlucas VenturesHemisphere Ventures LLCLakeside Capital+4 more

Miroculusmiroculus.comin

Automates complex biological protocols in a compact cartridge-based system for genomic sequencing

BiotechSan Francisco, US

Ferran Galindo(Director)inFoteini Christodoulou(Director)

BoardAlejandro Tocigl(Executive Officer, Director)in

Co-investors0BSCota CapitalID345Kayyak VenturesNazcaSun Mountain Capital+1 more

Pivot Biopivotbio.comin𝕏

Pivot Bio develops agricultural innovations focused on transforming farming practices through microbiology and genetics.

AgTechBiotechEmeryville, US

Alvin Tamsir(Executive Officer, Director)inKarsten Temme(Executive Officer, Director)inAlvin Tamsir, Ph.D.(Chief Science Officer & Co-Founder)Karsten Temme, Ph.D.(Chief Innovation Officer and Co-Founder)Chris Abbott(Chief Executive Officer)in

BoardRoger Wyse(Director)in

Co-investorsBreakthrough Energy VenturesCongruent VenturesDCVC (Data Collective)G2 Venture PartnersK3 VenturesK3V Ventures+10 more

Strateosstrateos.comin𝕏Apr 2019

Strateos develops remote access laboratory software and automation platforms that enable scientists to design, execute, and analyze experiments through cloud-based robotics and control systems.

AI & Machine LearningBiotechDeep TechRoboticsSaaSMenlo Park, US

Chris Krueger(Executive Officer)inMark Fischer-Colbrie(Executive Officer, Director)inDavid Lynch, PhD(Chief Executive Officer)Marc Siladi(Chief Operating Officer)in

BoardJoshua Wolfe(Director)Armen Vidian(Director)in

Co-investorsDCVC (Data Collective)Lux CapitalBlueStone Venture PartnersThird Rock VenturesAlumni VenturesDolby Family Ventures+6 more

Synthegosynthego.comin𝕏

Synthego develops CRISPR gene-editing and molecular diagnostics products, including custom CRISPR editors in mRNA or protein formats, base editors, and cell-free protein and RNA production systems.

BiotechDeep TechHealthtechMedical DevicesRedwood City, US

Paul John Dabrowski(Executive Officer, Director)Michael Jakub Dabrowski(Executive Officer, Director)Craig Christianson(CEO)in

BoardDrew Oetting(Director)inScott Nolan(Director)in

Co-investorsAAF Management Ltd.AME Cloud VenturesDeclaration PartnersFounders FundKhosla VenturesMenlo Ventures+11 more

Tempo Automationtempoautomation.com

San Francisco, US

Shashank Samala(Cofounder)Jeffrey McAlvay(Executive Officer, Director)Jesse Koenig(Executive Officer)

Co-investorsAlumni VenturesDolby Family VenturesGrit VenturesKeiretsu ForumLux CapitalPoint72 Ventures+5 more

TrueMLtrueml.coinSeries A · Sep 2014 · $5M

TrueML builds technology to modernize how consumers are engaged around debt collection and financial services, aiming for better consumer experiences and outcomes.

AI & Machine LearningFintechSaaS

Ohad SametinNadav Sametin

Co-investorsArbor VenturesNycaNyca PartnersRaptor GroupTenOneTen VenturesTop Corner Capital

Truviantruvianhealth.comin𝕏

Truvian builds an on-site blood diagnostics platform that combines clinical chemistry, immunoassay, and hematology testing in a single compact instrument.

BiotechDigital HealthMedical DevicesSan Diego, US

Dena Marrinucci(Co-Founder & Chief Operating Officer)inMichael J. Mina(Chief Medical and Strategy Officer)in

Co-investorsDns CapitalGreatPoint VenturesWittington VenturesDomain AssociatesEmbark VenturesMedical Excellence Capital+1 more

uBiome6sense.com

Account engagement platform helping B2B organizations achieve predictable revenue growth.

Amanda Kahlow(Founder)inJason Zintakin

Co-investorsB Capital GroupB4 CapitalBain Capital VenturesBase Venture Management, Inc.Battery VenturesField Ventures+13 more

uBiomeubiome.comMay 2016

San Francisco, US

Zachary Apte(Executive Officer, Director)Jessica Richman(Executive Officer, Director)

BoardJoseph Lonsdale(Director)Witt Wisebram(Director)

Co-investorsMilliways Ventures8VCDentsu VenturesSlow VenturesY Combinator

Verge Genomicsvergegenomics.comin𝕏

Verge Labs builds AI models trained on multimodal human patient data to predict drug targets and patient populations for clinical development, primarily in neuroscience and central nervous system (CNS) disease.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtechSan Francisco, US

Alice Zhang(Co-founder & CEO)inJason Chen(Cofounder)inEmily Ripka(Head of Product & Engineering)in

Co-investorsAgent CapitalBOLD LongevityDraper AssociatesFitz Gate VenturesGreat Oaks Venture CapitalKarlin Ventures+26 more

Vicarious FPCvicarious.comAcquired

Vicarious was a Bay Area AI/robotics startup founded in 2010 that developed brain-inspired AI software enabling industrial robots to perform complex warehouse tasks like picking, packing, and palletizing.

Palo Alto, US

David Scott Phoenix(Executive Officer, Director)Dileep George(Executive Officer, Director)

BoardDustin Moskovitz(Director)in

Co-investorsAmino CapitalDCVC (Data Collective)Felicis VenturesOlive Tree CapitalRealization Capital PartnersWipro Ventures+6 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Eat JustHealthdataNuMatPlanetary ResourcesRWXViridosViv

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.